L04AD Calcineurin inhibitors

No definition available.

Endpoint definition

FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries KELA purch., KELA reimb.

Medicine purchases: ATC L04AD
Medicine purchases: ATC: other data required >3 instances required

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector RX_L04AD

Extra metadata

First used in FinnGen datafreeze DF3

Summary Statistics

Key figures

All Female Male
Number of individuals 2124 1031 1093
Unadjusted prevalence (%) 0.82 0.70 0.97
Mean age at first event (years) 49.15 48.09 50.15

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.16 12.25 [7.26, 20.67] 6.0e-21 112
15 years 0.08 12.25 [7.26, 20.67] 6.0e-21 112
5 years 0.02 17.07 [10.16, 28.71] 9.6e-27 63
1 year 0.00 17.15 [8.46, 34.75] 3.1e-15 12

Correlations

Index endpoint: RX_L04AD – L04AD Calcineurin inhibitors
GWS hits:

Survival analyses between endpoints

Plot

before L04AD Calcineurin inhibitors
after L04AD Calcineurin inhibitors

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after L04AD Calcineurin inhibitors